We are live on ! Find out more
KBC Group

KBC Group Portfolio holdings

AUM $39.9B
1-Year Est. Return 29.7%
This Fund
S&P 500
This Quarter Est. Return
+0.55%
1 Year Est. Return
+29.7%
3 Year Est. Return
+99.77%
5 Year Est. Return
+133.11%
10 Year Est. Return
+496.57%
AUM
$10.8B
AUM Growth
-$884M
Cap. Flow
-$870M
Cap. Flow %
-8.04%
Top 10 Hldgs %
16.21%
Holding
1,353
New
94
Increased
424
Reduced
534
Closed
80

Top Buys

Rank Stock Value
1
CTSH icon
Cognizant
CTSH
+$36.9M
2
CAT icon
Caterpillar
CAT
+$35.6M
3
JPM icon
JPMorgan Chase
JPM
+$30.3M
4
SJM icon
J.M. Smucker
SJM
+$26.2M
5
INTC icon
Intel
INTC
+$24.6M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$58.6M
2
HPE icon
Hewlett Packard
HPE
+$42.2M
3
BABA icon
Alibaba
BABA
+$41.4M
4
TXN icon
Texas Instruments
TXN
+$35.2M
5
META icon
Meta Platforms (Facebook)
META
+$33.9M

Sector Composition

Rank Sector Weight
1 Technology 18.58%
2 Financials 18.08%
3 Healthcare 14.36%
4 Consumer Discretionary 11.3%
5 Industrials 10.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IONS icon
1176
Ionis Pharmaceuticals
IONS
$8.93B
$109K ﹤0.01%
2,489
+620
+33% +$31.5K
AEO icon
1177
American Eagle Outfitters
AEO
$2.94B
$108K ﹤0.01%
5,400
QQQ icon
1178
Invesco QQQ Trust
QQQ
$436B
$108K ﹤0.01%
675
TRK
1179
DELISTED
Speedway Motorsports, Inc.
TRK
$104K ﹤0.01%
5,822
+3,523
+153% +$68.1K
TREX icon
1180
Trex
TREX
$4.4B
$103K ﹤0.01%
3,776
-76,496
-95% -$2.11M
SGYP
1181
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$103K ﹤0.01%
56,500
+32,700
+137% +$69.1K
EPC icon
1182
Edgewell Personal Care
EPC
$1.3B
$101K ﹤0.01%
2,077
DAKT icon
1183
Daktronics
DAKT
$946M
$100K ﹤0.01%
+11,372
New +$105K
TDC icon
1184
Teradata
TDC
$2.88B
$100K ﹤0.01%
2,532
CCBG icon
1185
Capital City Bank Group
CCBG
$897M
$98K ﹤0.01%
3,975
-222
-5% -$5.42K
RWT
1186
Redwood Trust
RWT
$588M
$98K ﹤0.01%
6,321
-15,005
-70% -$225K
NEOG icon
1187
Neogen
NEOG
$2.05B
$92K ﹤0.01%
+2,760
New +$83.2K
WTI icon
1188
W&T Offshore
WTI
$525M
$90K ﹤0.01%
20,384
-122,924
-86% -$520K
CCRN
1189
DELISTED
Cross Country Healthcare
CCRN
$89K ﹤0.01%
8,007
-31,177
-80% -$391K
DVAX
1190
DELISTED
Dynavax Technologies
DVAX
$89K ﹤0.01%
4,500
+800
+22% +$13.8K
TRN icon
1191
Trinity Industries
TRN
$2.92B
$88K ﹤0.01%
3,764
VSI
1192
DELISTED
Vitamin Shoppe Inc.
VSI
$83K ﹤0.01%
19,041
-126,460
-87% -$552K
JBLU icon
1193
JetBlue
JBLU
$2.13B
$80K ﹤0.01%
+3,916
New +$83.3K
WEN icon
1194
Wendy's
WEN
$1.46B
$80K ﹤0.01%
4,557
-4,359
-49% -$72.3K
CRSP icon
1195
CRISPR Therapeutics
CRSP
$4.69B
$78K ﹤0.01%
1,700
+1,000
+143% +$41.3K
EBF icon
1196
Ennis
EBF
$554M
$78K ﹤0.01%
+3,938
New +$79.7K
TIVO
1197
DELISTED
Tivo Inc
TIVO
$75K ﹤0.01%
5,500
PBI icon
1198
Pitney Bowes
PBI
$2.39B
$69K ﹤0.01%
6,333
-488,115
-99% -$6.05M
AGO icon
1199
Assured Guaranty
AGO
$3.73B
$68K ﹤0.01%
1,879
-80,346
-98% -$2.83M
DXCM icon
1200
DexCom
DXCM
$29B
$68K ﹤0.01%
3,688

Similar funds

KBC Group's Q1 2018 Portfolio in Review

As of Q1 2018, KBC Group held 1,353 positions worth $10.8B, down 7.6% from $11.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

KBC Group withdrew a net $870M in Q1 2018, closing 80 positions and reducing 534 holdings. Its most notable exit was Calgon Carbon Corp, an estimated $16.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

Against the trend, KBC Group opened a new position in Loxo Oncology, Inc worth $8.57M.

  • KBC Group's largest Q1 2018 buy was Loxo Oncology, Inc: 74,261 shares worth $8.57M.
  • KBC Group added most to Cognizant in Q1 2018, an estimated $36.9M increase.
  • KBC Group's biggest Q1 2018 reduction was Apple, cutting an estimated $58.6M.
  • KBC Group fully exited Calgon Carbon Corp in Q1 2018, selling an estimated $16.5M.
  • KBC Group's ten largest holdings make up 16% of its $10.8B portfolio in Q1 2018.
  • KBC Group opened 94 new positions and closed 80 in Q1 2018.
  • KBC Group's portfolio value fell 7.6% quarter-over-quarter to $10.8B.

Based on KBC Group's 13F filing for Q1 2018, filed 9 May 2018.